AngioDynamics, Inc. (ANGO) vs BlossomHill Therapeutics, Inc. (BLSM)
A side-by-side comparison of AngioDynamics, Inc. and BlossomHill Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ANGO
AngioDynamics, Inc.
$14.75HealthcareDelayed quote: Oct 6, 2026, 12:00 PM EDT
BLSM
BlossomHill Therapeutics, Inc.
$19.06HealthcareDelayed quote: Oct 6, 2026, 11:59 AM EDT
Total return — ANGO vs BLSM
growth of $100 · dividends reinvested · last 1yANGO +2.3% (+2.3%/yr)BLSM +24.6% (+24.6%/yr)BLSM compounded faster over this window
ANGO BLSM
ANGO vs BLSM: by the numbers
- •ANGO is the larger company ($609M vs $554M market cap).
- •Both run net losses; BLSM's is the smaller (0.00% vs -11.48% net margin).
Metrics side by side
Valuation
| Metric | ANGO | BLSM |
|---|---|---|
| P/S ratio | 1.90 | N/A |
| P/B ratio | 3.57 | N/A |
| FCF yield | 0.08% | N/A |
Profitability
| Metric | ANGO | BLSM |
|---|---|---|
| Gross margin | 54.62% | 0.00% |
| Operating margin | -12.47% | 0.00% |
| Net margin | -11.48% | 0.00% |
| ROE | -21.51% | N/A |
| ROIC | -20.75% | -43.41% |
Growth (annualized)
| Metric | ANGO | BLSM |
|---|---|---|
| Revenue CAGR (5Y) | 1.93% | N/A |
| FCF CAGR (5Y) | -51.49% | N/A |
| Total return CAGR (5Y) | -10.80% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.